UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 27, 2020
Accession Number:
0001341004-20-000226
Submission Type:
POS AM
CIK:
0001036141
Company Name:
Correvio Pharma Corp.
File Number:
333-85922